SwedenLivingWorldBusinessSportsEntertainmentFAQ

Bioarctic

EU Approves Alzheimer's Drug Lecanemab for Sale

The Alzheimer's drug lecanemab has been granted permission by the EU Commission for sale within the union as well as in Iceland, Liechtenstein, and Norway, announces the Swedish company Bioarctic in a press release. The permission is given since EMA, the EU's pharmaceutical authority, approved lecanemab last winter.
EU Approves Alzheimer's Drug Lecanemab for Sale

Swedish drug candidate classified in the USA

The American drug authority FDA has given a special classification to the drug candidate exidavnemab from Swedish Bioarctic, according to a press release from the pharmaceutical company. The classification concerns the treatment of multiple system atrophy (MSA).
Swedish drug candidate classified in the USA

Long wait for new Alzheimer's drug

After years of waiting, the message came: the EU's pharmaceutical authority says yes to the drug lecanemab against Alzheimer's. But the question is which patients can be treated, and when – and if it is introduced in the country's regions at all.
Long wait for new Alzheimer's drug

The UK Approves Alzheimer's Medication

Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom. .
The UK Approves Alzheimer's Medication

Alzheimer's medicine generates millions for Swedish Bioarctic

The sale of the Alzheimer's medicine Leqembi has generated 6. 3 billion yen, equivalent to around 450 million kronor, during the second quarter.
Alzheimer's medicine generates millions for Swedish Bioarctic

Medicine Stop a Hard Blow for Alzheimer's Patients

The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.
Medicine Stop a Hard Blow for Alzheimer's Patients

More approve Alzheimer's medication

Israel, and just the other day Hong Kong, has now approved the Alzheimer's drug Leqembi for use, which the USA, Japan, South Korea, and China have done previously. This is stated by the Swedish pharmaceutical company Bioarctic in a press release.
More approve Alzheimer's medication
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald